Fenwick made waves at Euromoney’s LMG Life Sciences 2024 Americas Awards, earning Impact Deal of the Year for the firm’s representation of Shockwave, a pioneer in cardiovascular disease treatment, in its $13.1 billion acquisition by Johnson & Johnson. By combining Shockwave's innovative therapeutic technologies with Johnson & Johnson's extensive resources and market reach, the acquisition marks momentous progress toward accelerating the development and deployment of life-changing cardiovascular treatments for patients around the world.
The annual LMG Life Sciences Americas Awards honor the leading firms and practitioners in the life sciences sector in the U.S., Canada, and Brazil.
As the life sciences deal market picked up steam this year, Fenwick’s deal activity earned the firm placement on LMG Life Sciences’ Firm of the Year shortlists in the corporate and venture capital categories.
Additionally, the following partners received shortlist recognitions for Attorney of the Year awards in their respective practice areas:
To see the full list of 2024 Americas Awards winners, visit the LMG Life Sciences website.